Cancer Biotherapy and Radiopharmaceuticals This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Systems Biology Approach to Investigate Biomarkers, Boron-10 Carriers, and Mechanisms Useful for Improving Boron Neutron Capture Therapy
Cancer Biotherapy and Radiopharmaceuticals, Ahead of Print. (Source: Cancer Biotherapy and Radiopharmaceuticals)
Source: Cancer Biotherapy and Radiopharmaceuticals - October 21, 2022 Category: Cancer & Oncology Authors: Davide Perico Dario Di Silvestre Shoji Imamichi Yu Sanada Mitsuko Masutani Pier Luigi Mauri Source Type: research

Inhibitory Effect of Lentivirus-Mediated Gag-Caspase-8 on the Growth of HER-2 Overexpressing Primary Human Breast Cancer Cells
Cancer Biotherapy and Radiopharmaceuticals,Volume 37, Issue 8, Page 720-728, October 2022. (Source: Cancer Biotherapy and Radiopharmaceuticals)
Source: Cancer Biotherapy and Radiopharmaceuticals - October 12, 2022 Category: Cancer & Oncology Authors: Min Wang Xiping Li Wei Xie Li Zhong Yu Leng Xiaoqiong Chen Mei Yang Ling Qi Zhenda Zhang Linjian Liu Dongxin Tang Source Type: research

64Cu-/177Lu-Cetuximab Theranostic Pair: May the Single 64Cu-Cetuximab Diagnostic Scan Be Acquired at Any Time After Injection?
Cancer Biotherapy and Radiopharmaceuticals, Ahead of Print. (Source: Cancer Biotherapy and Radiopharmaceuticals)
Source: Cancer Biotherapy and Radiopharmaceuticals - October 10, 2022 Category: Cancer & Oncology Authors: Eric Laffon Roger Marthan Source Type: research

Strategies for Preclinical Studies Evaluating the Biological Effects of an Accelerator-Based Boron Neutron Capture Therapy System
Cancer Biotherapy and Radiopharmaceuticals, Ahead of Print. (Source: Cancer Biotherapy and Radiopharmaceuticals)
Source: Cancer Biotherapy and Radiopharmaceuticals - September 26, 2022 Category: Cancer & Oncology Authors: Natsuko Kondo Mitsuko Masutani Shoji Imamichi Yoshitaka Matsumoto Kei Nakai Source Type: research

First-In-Human Pilot PET Immunoimaging Study of 64Cu-Anti-Carcinoembryonic Antigen Monoclonal Antibody (hT84.66-M5A) in Patients with Carcinoembryonic Antigen-Producing Cancers
Cancer Biotherapy and Radiopharmaceuticals, Ahead of Print. (Source: Cancer Biotherapy and Radiopharmaceuticals)
Source: Cancer Biotherapy and Radiopharmaceuticals - September 26, 2022 Category: Cancer & Oncology Authors: Jeffrey Y.C. Wong David M. Yamauchi Vikram Adhikarla Jennifer Simpson Paul H. Frankel Yuman Fong Kurt A. Melstrom Yi-jen Chen Behrooz D. Salehian Yanghee Woo Savita V. Dandapani David M. Colcher Erasmus K. Poku Paul J. Yazaki Anna M. Wu John E. Shively Source Type: research

Radiochemical Quality Control Methods for Radium-223 and Thorium-227 Radiotherapies
Cancer Biotherapy and Radiopharmaceuticals, Ahead of Print. (Source: Cancer Biotherapy and Radiopharmaceuticals)
Source: Cancer Biotherapy and Radiopharmaceuticals - September 23, 2022 Category: Cancer & Oncology Authors: Abbie Hasson Wen Jiang Nadia Benabdallah Peng Lu Mark S. Longtine Bradley J. Beattie Lucy Summer Hanwen Zhang Richard L. Wahl Diane S. Abou Daniel L.J. Thorek Source Type: research

Animal Tumor Models for Boron Neutron Capture Therapy Studies (Excluding Central Nervous System Solid Tumors)
Cancer Biotherapy and Radiopharmaceuticals, Ahead of Print. (Source: Cancer Biotherapy and Radiopharmaceuticals)
Source: Cancer Biotherapy and Radiopharmaceuticals - September 21, 2022 Category: Cancer & Oncology Authors: Andrea Monti Hughes Amanda E. Schwint Source Type: research

Rodent Brain Tumor Models for Studies Focusing on Boron Neutron Capture Therapy
Cancer Biotherapy and Radiopharmaceuticals, Ahead of Print. (Source: Cancer Biotherapy and Radiopharmaceuticals)
Source: Cancer Biotherapy and Radiopharmaceuticals - September 19, 2022 Category: Cancer & Oncology Authors: Rolf F. Barth David E. Carpenter Source Type: research

Long Non-Coding RNA AC008972.1 as a Novel Therapeutic Target for Prostate Cancer
Cancer Biotherapy and Radiopharmaceuticals, Ahead of Print. (Source: Cancer Biotherapy and Radiopharmaceuticals)
Source: Cancer Biotherapy and Radiopharmaceuticals - September 9, 2022 Category: Cancer & Oncology Authors: Qingqi Zeng Jia Liu Qijin Wu Ruiyu Song Wen Miao Yuting Ma Hongbao Yang Source Type: research

Expression of Concern re: CircSMARCA5 Facilitates the Progression of Prostate Cancer Through miR-432/PDCD10 Axis (DOI: 10.1089/cbr.2019.3490)
Cancer Biotherapy and Radiopharmaceuticals, Ahead of Print. (Source: Cancer Biotherapy and Radiopharmaceuticals)
Source: Cancer Biotherapy and Radiopharmaceuticals - August 4, 2022 Category: Cancer & Oncology Source Type: research

Expression of Concern re: Exosome-Mediated Transfer of Long Noncoding RNA HOTAIR Regulates Temozolomide Resistance by miR-519a-3p/RRM1 Axis in Glioblastoma (doi: 10.1089/cbr.2019.3499)
Cancer Biotherapy and Radiopharmaceuticals,Volume 37, Issue 6, Page 515-515, August 2022. (Source: Cancer Biotherapy and Radiopharmaceuticals)
Source: Cancer Biotherapy and Radiopharmaceuticals - July 29, 2022 Category: Cancer & Oncology Source Type: research

The Regulatory Role of SNORD35A in Pancreatic Cancer Involves the HGF/C-Met Pathway
Cancer Biotherapy and Radiopharmaceuticals, Ahead of Print. (Source: Cancer Biotherapy and Radiopharmaceuticals)
Source: Cancer Biotherapy and Radiopharmaceuticals - July 8, 2022 Category: Cancer & Oncology Authors: Fuxue Chen Yubei Zheng Huibin Zhou Chenwei Li Source Type: research

Highly Expressed LINC00958 Modulates the Growth and Epithelial-Mesenchymal Transition of Bladder Cancer Cells Through SAPK/JNK Signaling Pathway
Cancer Biotherapy and Radiopharmaceuticals, Ahead of Print. (Source: Cancer Biotherapy and Radiopharmaceuticals)
Source: Cancer Biotherapy and Radiopharmaceuticals - June 29, 2022 Category: Cancer & Oncology Authors: Ying Xiao Lei He Yipeng Dong Yeqing Huang Limin Ma Wenguang Li Source Type: research

Feasibility of 18F-FDG Labelling of Leucocytes in a Centre Without an On-Site Cyclotron and Monitoring of Radiation Dose to Occupational Worker in the Labelling Procedure
Cancer Biotherapy and Radiopharmaceuticals, Ahead of Print. (Source: Cancer Biotherapy and Radiopharmaceuticals)
Source: Cancer Biotherapy and Radiopharmaceuticals - June 28, 2022 Category: Cancer & Oncology Authors: Parul Thakral Divya Manda Subha Shankar Das Pankaj Tandon Virupakshappa CB Dharmender Malik Ishita Sen Source Type: research

Metadherin Promotes the Development of Bladder Cancer by Enhancing Cell Division
Cancer Biotherapy and Radiopharmaceuticals, Ahead of Print. (Source: Cancer Biotherapy and Radiopharmaceuticals)
Source: Cancer Biotherapy and Radiopharmaceuticals - June 14, 2022 Category: Cancer & Oncology Authors: Shi-Shuo Wang Gao-Qiang Zhai Gang Chen Zhi-Guang Huang Yu Zhang Li-Jie Zhang Yi-Wu Dang Sheng-Hua Li Hai-Biao Yan Source Type: research